AbbVie Inc. against Pfizer — live side-by-side technical comparison.
Prices as of 2026-11-06T21:01:45+00:00 UTC · updates daily
ABBV leads 5 of the 5 windows we measure — over 1 month ABBV is +7.3% and PFE +5.0%; over year to date ABBV is +27.5% and PFE +18.0%. The ABBV/PFE price ratio stands at 9.9119, above its 50-day average of 9.4596, and above the 200-day average of 8.8875. A ratio above its own average means ABBV is gaining on PFE; on this reading the recent edge belongs to ABBV.
| ABBV | PFE | |
|---|---|---|
| Price | $291.31 | $29.39 |
| 1 day | +1.1%lead | -1.6% |
| 5 days | -1.2%lead | -3.7% |
| 1 month | +7.3%lead | +5.0% |
| 6 months | +42.1%lead | +10.8% |
| Year to date | +27.5%lead | +18.0% |
| 52-week position | 90% of range | 74% of range |
| 52-week range | $190.75–$302.93 | $23.62–$31.44 |
| vs 50-day average | above $271.95 | above $28.74 |
| vs 200-day average | above $238.94 | above $26.91 |
| RSI (14) | 59 | 50 |
| Next earnings | 2026-10-30 | 2027-02-02 |
ABBV trades at $291.31, above its 50-day average of $271.95, and above the 200-day at $238.94. It sits at 90% of its 52-week range ($190.75–$302.93); 14-day RSI is 59, in neutral territory; an average session moves it about 2.7%. For levels, the first level overhead is $294.89 (1.2% away) and the first support below is $275.00 (5.6% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
PFE trades at $29.39, above its 50-day average of $28.74, and above the 200-day at $26.91. It sits at 74% of its 52-week range ($23.62–$31.44); 14-day RSI is 50, in neutral territory; an average session moves it about 2.7%. For levels, the first level overhead is $30.00 (2.1% away) and the first support below is $29.21 (0.6% down). On the checklist the page runs for every asset, 3 of 6 checks read bullish — the lean is bullish.
Both move about the same amount day to day (2.7% and 2.7% of price), so the same position size carries comparable risk in either.
The comparison turns on those levels: ABBV clearing $294.89 or losing $275.00; PFE clearing $30.00 or losing $29.21. Until one of them gives way, the relative reading above stands.